MicroPort Endovascular MedTech Ltd (688016) — Cash Flow-to-Debt Ratio
MicroPort Endovascular MedTech Ltd (688016) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥46.79 Million could theoretically repay 0% of its total liabilities (CN¥750.07 Million) in one year. See how financially flexible is MicroPort Endovascular MedTech Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
MicroPort Endovascular MedTech Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for MicroPort Endovascular MedTech Ltd across 9 annual periods. For the full cash flow conversion analysis, see MicroPort Endovascular MedTech Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for MicroPort Endovascular MedTech Ltd (2016–2024)
Year-by-year debt coverage analysis for MicroPort Endovascular MedTech Ltd. Check cash flow quality index of MicroPort Endovascular MedTech Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.80x | CN¥373.60 Million | CN¥469.13 Million | ▼ -46.7% |
| 2023 | 1.49x | CN¥571.22 Million | CN¥382.63 Million | ▲ +12.9% |
| 2022 | 1.32x | CN¥333.76 Million | CN¥252.49 Million | ▲ +1.9% |
| 2021 | 1.30x | CN¥300.25 Million | CN¥231.47 Million | ▼ -15.2% |
| 2020 | 1.53x | CN¥217.44 Million | CN¥142.09 Million | ▼ -4.1% |
| 2019 | 1.60x | CN¥143.20 Million | CN¥89.74 Million | ▼ -21.4% |
| 2018 | 2.03x | CN¥106.85 Million | CN¥52.66 Million | ▲ +6.0% |
| 2017 | 1.91x | CN¥69.36 Million | CN¥36.24 Million | ▲ +314.1% |
| 2016 | 0.46x | CN¥30.13 Million | CN¥65.22 Million | — |